Varivax vaccine with diluents
Ended Awarded Last action
- Contract number
- SPE2DR26FBTP8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,594
Award facts
- Contract value 100% obligated
- $44,593.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $44,593.50 by the Defense Logistics Agency on January 27, 2026, for the supply of Varivax vaccine with diluents. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of February 18, 2026. This delivery order operates under a larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2031, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Amerisourcebergen's role as a critical federal pharmaceutical vendor reflects its established position within the Defense Logistics Agency's medical supply chain. The company's extensive portfolio encompasses specialty medications, brand-name and generic drugs, vaccines, and other medical commodities across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular award for Varivax vaccine supports the Department of Defense's immunization requirements and demonstrates the company's continued capacity to fulfill federal medical procurement needs through open competition and established contract mechanisms.
Quick answers
Who was awarded contract SPE2DR26FBTP8?
SPE2DR26FBTP8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FBTP8 worth?
The government has obligated $44,594 on SPE2DR26FBTP8.
Is contract SPE2DR26FBTP8 an order under another contract?
Yes. SPE2DR26FBTP8 is a delivery order under SPE2DR25D2002, an indefinite delivery contract.
Was contract SPE2DR26FBTP8 competed?
The extent of competition for SPE2DR26FBTP8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award